PARK-IT | Unobtrusive, continuous and quantitative assessment of Parkinson’s disease: hard evidence for optimal disease management with information technologies

Summary
Sense4Care S.L. (S4C) is high-tech SME constituted in Barcelona in 2013 as a spin-off of the Universitat
Politècnica de Catalunya - BarcelonaTech (UPC) with a clear objective: taking to the market the results of several
research projects. UPC itself holds 5% of the shares of the company, and the rest belongs to professors,
researchers and investors. UPC was the Coordinator and main beneficiary of the FP7-ICT project called
REMPARK1 project, and has legally transferred the exploitation rights of the project results to S4C, with the aim
of commercialising a product that can dramatically improve the lives of Parkinson’s Disease (PD) sufferers.

The main result from the FP7-REMPARK project is the kinetic monitor PARK-IT, which can be exploited as a
standalone product. PARK-IT is a new gold-standard, continuous and quantitative monitoring medical device for
assessing the status of Parkinson Disease patients. PARK-IT device, based in movement detection and complex
algorithms, allows the doctors to precisely adjust the medication of PD patients, overcoming one of the main
problems that PD patients face. It constitutes a disruptive innovation answering to an unmet need.

The present innovation business project is therefore focused in taking this device to the market through a
clear and innovative business model.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/672228
Start date: 01-06-2015
End date: 30-11-2015
Total budget - Public funding: 71 429,00 Euro - 50 000,00 Euro
Cordis data

Original description

Sense4Care S.L. (S4C) is high-tech SME constituted in Barcelona in 2013 as a spin-off of the Universitat
Politècnica de Catalunya - BarcelonaTech (UPC) with a clear objective: taking to the market the results of several
research projects. UPC itself holds 5% of the shares of the company, and the rest belongs to professors,
researchers and investors. UPC was the Coordinator and main beneficiary of the FP7-ICT project called
REMPARK1 project, and has legally transferred the exploitation rights of the project results to S4C, with the aim
of commercialising a product that can dramatically improve the lives of Parkinson’s Disease (PD) sufferers.

The main result from the FP7-REMPARK project is the kinetic monitor PARK-IT, which can be exploited as a
standalone product. PARK-IT is a new gold-standard, continuous and quantitative monitoring medical device for
assessing the status of Parkinson Disease patients. PARK-IT device, based in movement detection and complex
algorithms, allows the doctors to precisely adjust the medication of PD patients, overcoming one of the main
problems that PD patients face. It constitutes a disruptive innovation answering to an unmet need.

The present innovation business project is therefore focused in taking this device to the market through a
clear and innovative business model.

Status

CLOSED

Call topic

ICT-37-2014-1

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
H2020-EU.2.1.1.0. INDUSTRIAL LEADERSHIP - ICT - Cross-cutting calls
H2020-SMEINST-1-2014
ICT-37-2014-1 Open Disruptive Innovation Scheme (implemented through the SME instrument)
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-1-2014
ICT-37-2014-1 Open Disruptive Innovation Scheme (implemented through the SME instrument)